Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $682,000 | $373,000 | $358,000 | $136,000 | — | — | — | — | — |
| Gross profit | $67,000 | $112,000 | $162,000 | $75,000 | — | — | — | — | — |
| Research & development | $20.5M | $11.3M | $8.9M | $5.2M | $2.6M | $1.5M | $891,126 | $250,640 | — |
| Operating expenses | $51.1M | $26.0M | $26.4M | $28.7M | $17.1M | $17.3M | $2.5M | $5.8M | $175,000 |
| Operating income | −$51.1M | −$25.9M | −$26.2M | −$28.6M | −$17.1M | −$17.3M | −$2.5M | −$5.8M | −$175,000 |
| EBITDAderived | −$46.7M | −$22.1M | −$22.9M | −$26.8M | −$17.1M | −$17.3M | −$2.5M | −$5.8M | — |
| Net income | −$18.7M | −$68.5M | −$27.0M | −$26.0M | −$27.9M | −$24.7M | −$8.4M | −$10.5M | −$175,000 |
| Basic EPSper diluted share | -$0.11 | -$0.73 | -$0.42 | -$0.73 | -$0.96 | -$0.88 | -$1.14 | -$2.22 | -$0.19 |
| Diluted EPSper diluted share | -$0.11 | -$0.73 | -$0.42 | -$0.73 | -$0.96 | -$0.88 | -$1.14 | -$2.22 | -$0.19 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 11, 2026Form 4 | Roberts Christopher BruceCFO and General Counsel | SellCommon Stock | 9.4K | $7.85 | $73.5K | 1.12M |
| Mar 10, 2026Form 4 | Roberts Christopher BruceCFO and General Counsel | SellCommon Stock | 68.9K | $7.85 | $540.9K | 1.13M |
| Jan 7, 2026Form 4 | Begliarbekov MilanChief Operating Officer | SellCommon Stock | 2.9K | $11.85 | $33.9K | 24.2K |
| Sep 15, 2025Form 4 | FAGENSON ROBERT BDirector | SellCommon Stock · indirect | 5.0K | $16.88 | $84.4K | 0 |
| Sep 12, 2025Form 4 | FAGENSON ROBERT BDirector | SellCommon Stock · indirect | 15.0K | $15.62 | $234.3K | 5.0K |